The Community College of Denver (CCD) has just launched a cannabis business program in Colorado.

The new program offers students the opportunity to earn an Associate of Applied Science degree designed to prepare them to become business managers and operators within a cannabis enterprise.

“Thanks to our strong ties to the local business community, we are able to equip students with the skills they need to succeed in the fastest-growing industry in the US,” CCD president Dr. Marielena DeSanctis said.

And randomly, US cannabis retailer Jushico has announced a partnership with Tom Hanks’ son Colin to bring his handkerchief line – Hanks Kerchiefs – into select dispensary locations.

“I knew this was the perfect opportunity to bring a bit of timeless style to cannabis consumers,” Jushico CEO, chairman and founder Jim Cacioppo.

Over in the motherland, London-based Kanabo have just struck a deal that CEO Avihu Tamir said will make it “Europe’s biggest publicly traded cannabis company.

The company is set to buy the European operations of Canada’s Materia, a cannabis processor and supplier with access to hundreds of pharmacies across Germany – whose market was estimated at over €200M last year.

And on Aussie shores Compass Cannabis has moved into Australia with its holistic cannabis clinics.

 

ASX Winners

Medlab Clinics (ASX:MDC) jumped 19% this week after the US Patent Office issued a Notice of Allowance status for the company’s NRGBiotic product for treating, preventing, or ameliorating depression or a depressive disorder.

“NRGBioticTM has both the formulation and capabilities of that formulation previously approved in Australia,” CEO Dr Sean Hall said.

“From a commercial aspect, NRGBioticTM is a branded line here in Australia, and will now go to our partnering network in the Northern Hemisphere.”

Next in line was IDT Australia (ASX:IDT), up 13% and Epsilon Healthcare (ASX:EPN), up 7% – both on no news.

Live Verdure (ASX:LV1) was up 6%, reporting online sales in the June quarter increased by ~32% on the previous quarter after it commenced distribution on the Amazon Australia marketplace.
 

ASX Losers

The biggest loser was Eve Investments (ASX:EVE), down 20% on no news, followed by Cann Group (ASX:CAN), down 16% after announcing a delay in the settlement of its $20m placement by two days.

The placement is planned for cost saving initiatives as the company moves to large scale production with the commissioning of its new manufacturing facility near Mildura.